CompletedNot Applicable

Cerebrospinal Fluid Proteome in Hydrocephalus

France100 participantsStarted 2013-03

Plain-language summary

PROLIPHYC is a collaborative prospective study that aims at discovering deep cerebrospinal fluid (CSF) proteome with a new clinically-compatible proteomics strategy, in a cohort of 100 patients suspected of neurodegenerative diseases and/or normal pressure hydrocephalus.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gait problems, cognitive decline, urinary incontinence and enlarged ventricles on imaging Exclusion Criteria: * Psychiatric disorders * Lumbar punction contraindication * RMI contraindication

What they're measuring

CSF proteome measure

Timeframe: 48 hours

Trial details

NCT IDNCT02016352

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-09

View on ClinicalTrials.gov More Normal Pressure Hydrocephalus trials